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Objective: Long-term weight loss is important and difficult to achieve 
for many women with polycystic ovary syndrome (PCOS). Lifestyle 
interventions (LS) in PCOS have shown moderate short-term ef-
fects. Three-component LS that combine nutrition advice, exercise, 
and cognitive behavioral therapy have not been tested in long-term 
interventions.
Methods: Women (N = 183) with PCOS who were trying to conceive and 
had BMI > 25 kg/m2 were assigned to 20 group sessions of cognitive be-
havioral therapy combined with nutrition advice and exercise (LS with or 
without Short Message Service [SMS] via mobile phone) or care as usual 
(CAU).
Results: More weight loss was observed in LS than in CAU (P < 0.001). 
Adding SMS was even more effective (P = 0.017). In CAU, 13 of 60 (21.8%) 
succeeded in achieving a 5% weight loss, as did 32 of 60 (52.8%) in LS 
without SMS and 54 of 63 (85.7%) in LS with SMS. The odds of achieving 
a 5% weight loss were 7.0 (P < 0.001) in LS compared with CAU. More 
than 18 of 60 (29.0%) of the women in CAU gained weight versus 5 of 60 
(8.5%) and 2 of 63 (3.1%) in LS without or with SMS, respectively. The 
overall dropout rate was 116 of 183 (63.4%).
Conclusions: A three-component LS program resulted in reasonable weight 
loss in women with PCOS. Adding SMS resulted in more weight loss.
Obesity (2020) 28, 2134-2141. 
Introduction
The prevalence of overweight and obesity is significantly higher in women diagnosed 
with polycystic ovary syndrome (PCOS) compared with women without PCOS (1). 
Most women with PCOS suffer from overweight and obesity throughout their entire 
life-span (2). Obesity worsens the reproductive, metabolic, and psychological symp-
toms of PCOS (2). Weight loss can improve psychological symptoms (depression, 
anxiety, and quality of life), reproductive function (menstrual cyclicity, ovulation, and 
fertility), and metabolic symptoms (insulin resistance and risk factors for cardiovascu-
lar disease and type 2 diabetes mellitus) even when weight remains in the overweight 
or obesity range (3). Therefore, multidisciplinary interventions are the first-line treat-
ment for weight loss in women with PCOS (4). A multidisciplinary approach consists 
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Study Importance
What is already known?
►	Most women with PCOS suffer from 
overweight and obesity throughout their 
entire life-span.
►	Obesity worsens the reproductive, met-
abolic, and psychological symptoms of 
PCOS.
►	 It is not clear whether lifestyle interven-
tions are effective in the long term.
What does this study add?
►	A 1-year three-component lifestyle inter-
vention with cognitive behavioral therapy 
resulted in more weight loss compared 
with 1 year of care as usual (CAU) in 
which participants were encouraged to 
lose weight through publicly available 
services.
►	The odds of achieving a 5% weight loss 
were 7.0 in the lifestyle group compared 
with CAU (P = 0.008)
►	More than 17 of 60 (29.0%) of the 
women in CAU, 5 of 60 (8.5%), and 2 
of 63 (3.1%) in lifestyle without or with 
SMS, respectively, gained weight.
How might these results change the 
focus of clinical practice?
►	Multidisciplinary programs are effective 
for relevant and sustainable weight loss 
in women with PCOS.
►	Additional E-health tools are useful in 
lifestyle interventions to achieve more 
weight loss.
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of three components: 1) modifying diet 2) increasing exercise, and 
3) cognitive behavioral therapy (CBT) to address weight loss and 
weight maintenance (5). The combination of these three components 
contributes to the final success of treatment. Three-component life-
style interventions (LS) are more effective in establishing long-term 
weight loss in the general population, as compared with one- or 
two-component LS. A meta-analysis concluded that three-compo-
nent LS are effective in the general population: 66% of the partici-
pants were able to reach a weight loss of 5% or more after 1 year (6). 
Some define successful weight loss as ≥10% weight loss maintained 
for at least 1 year, whereas others propose sustained weight loss of 
about 5% to 10% (7). In the general population, regaining weight (8), 
treatment adherence, and dropout (9) are major problems in current 
LS. In a 2013 meta-analysis, no patient- or LS-related factors could 
be identified that were related to dropout in the general population 
(9). A possible solution to increase therapy adherence and reduce 
dropout in obesity treatment in general is embedded or personally 
tailored E-health applications (10).
In women with PCOS, several one-, two-, and three-component life-
style programs have been tested (3,11,12). Many LS focused on diet 
and exercise and included no behavioral modification like the 16-week 
intervention of Kazemi and colleagues (13), the 20-week intervention 
of Thomson and colleagues (14) (n = 94), and the 16-week intervention 
(n = 50) of Legro and colleagues (15), which also included weight-loss 
medication. Some LS focused on CBT only or included CBT tech-
niques, like the pilot intervention of Cooney and colleagues (n = 33) 
that compared 16 individual 30-minute nutrition/exercise counseling 
sessions to 8 additional 30-minute brief CBT sessions (16). Abdollahi 
and colleagues invested eight CBT sessions of 45 to 60 minutes (n = 74) 
compared with a control group whose members received no treatment 
(17). Oberg and colleagues performed an intervention of 4 months 
(n = 68) that included three group meetings per month (18) delivered 
by a lifestyle coach. The lifestyle coach discussed topics like weight 
control, personal leadership, mindfulness, physical activity, and diet. 
Only a small number of studies tested three-component LS. The 
three-component intervention by Dokras and colleagues was a 16-week 
program (n = 149) that included caloric restriction by meal replacement 
products, increased physical activity, and counseling in behavioral 
modification strategies that were not described in detail (19). Another 
three-component intervention was an observational study (n = 33) per-
formed by de Frène and colleagues, which consisted of a 24-week diet, 
exercise, and psychological intervention (20). In conclusion, previous 
LS for women with PCOS covered short study periods of 24 weeks 
at most, had small sample sizes, were not group-based interventions, 
and did not use a structured CBT protocol. The present randomized 
controlled trial (RCT) differed from previous LS studies because it 1) 
examined the beneficial effect of three components (CBT/diet/exer-
cise), 2) used a structured CBT protocol, 3) addressed the development 
of a personal healthy diet rather than weight loss through weight-loss 
products, 4) was supervised by two physical exercise therapists and 
consisted of different sports disciplines and activities, 5) was conducted 
over a longer period (12 months), and 6) was tested in a large sample. 
Hence, the primary aim of this RCT was to examine whether a three- 
component intervention was effective to decrease weight compared 
with care as usual (CAU) in women with PCOS. Furthermore, we eval-
uated whether including Short Message Service (SMS) in the inter-
vention was effective in supporting behavioral change and sustainable 
weight loss. We hypothesized that the three-component intervention 
(with or without SMS) was more effective to decrease weight in 12 
months compared with CAU.
Methods
Study design
We performed a longitudinal RCT to measure the effectiveness of a 
three-component, multidisciplinary, 1-year LS program in women with 
PCOS and elevated BMI. The Medical Research Ethics Committee of 
the Erasmus MC in Rotterdam approved this study (reference number: 
MEC 2008-337), which was registered at the Netherlands Trial Register 
(NTR2450).
Participants
We conducted the study at the Division of Reproductive Endocrinology 
and Infertility, Department of Obstetrics and Gynecology, Erasmus MC, 
Rotterdam, the Netherlands. Women were eligible if they 1) were diag-
nosed with PCOS according to the Rotterdam 2003 consensus criteria, 2) 
had BMI > 25 kg/m2, 3) were between 18 and 38 years old, and 4) wished 
to become pregnant. Women with an inadequate command of the Dutch 
language, severe mental illness, obesity with another somatic cause, ovar-
ian tumors that lead to androgen excess, or adrenal diseases were not 
eligible for the study. Participants did not use any medication like oral 
contraceptives or metformin during the study period. We excluded women 
who became pregnant during the study. Weight loss is the first line of 
treatment for all patients who have overweight or obesity prior to all fer-
tility treatments at the Erasmus MC. Therefore, we informed all patients 
with PCOS and BMI > 25 about this study as part of our standard treat-
ment policy. More information can be found in the study protocol (21). 
All women met at least two of three Rotterdam 2003 consensus criteria: 
Oligomenorrhea was defined as a menstrual cycle of less than 21 days 
or more than 35 days and amenorrhea was defined as absence of men-
strual bleeding. Hyperandrogenism was defined as modified Ferriman 
Gallwey score ≥5 and/or biochemical symptoms of androgen excess (Free 
Androgen Index [FAI] cutoff >4.5 and/or total testosterone >3.0, testos-
terone measured with liquid chromatography-tandem mass spectrometry: 
FAI cutoff >2.9 and/or total testosterone >2.0 nmol/L). Polycystic ovarian 
morphology was defined as ≥12 follicles (measuring 2 to 9 mm in diam-
eter) and/or ovarian volume >10 cm3 in at least one ovary using an ultra-
sound machine with a transvaginal probe of <8 MHz .
Experimental design
Participants were assigned to either 1 year of 1) 20 group sessions of 
CBT, nutrition advice, and exercise; 2) 20 group sessions of CBT, nu-
trition advice, and exercise with an additional 9 months of electronic 
feedback through SMS via their mobile phone; or 3) CAU (Figure 1). 
Written informed consent was obtained from all participants prior to the 
study. At baseline, participants were randomized at a 1:1:1 ratio using a 
computer-generated random numbers table. A research nurse, who was 
not involved in the study, carried out the randomization. The assign-
ment was made by sequentially numbered, identical, sealed envelopes, 
each containing a letter designating the allocation. After the inclusion 
of 150 patients, we applied an interim analysis on behalf of the Grant 
Foundation. All participants visited the outpatient clinic every 3 months.
Outcomes
The primary aim of this study was to test whether the LS program is 
more effective in decreasing weight compared with CAU, as well as 
whether an LS program with SMS is more effective than a program 
without SMS to decrease weight. Secondary outcomes included BMI, 
weight loss ≥5% and ≥10%, weight gain, waist and hip circumference, 
waist-hip ratio, and dropout. All outcome variables were measured by 
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a standardized protocol at the start of the study (T0) and again at 3 
months (T1), 6 months (T2), 9 months (T3), and 12 months (T4).
Lifestyle intervention
The 1-year multidisciplinary LS program aimed to 1) change cogni-
tions, 2) improve dietary habits, 3) encourage and promote physical 
activity, and 4) activate social support. It consisted of 20 CBT group 
sessions of 2.5 hours over the course of 1 year. Important principles 
and techniques of the CBT component were self-monitoring, realis-
tic and achievable goal setting, developing new coping skills to han-
dle or prevent relapses, and promotion of alternative behaviors during 
critical emotional situations or negative mood states (22). In addition, 
cognitive restructuring was used for challenging dysfunctional eating, 
body-related beliefs, and schemas using thought records (23). All CBT 
techniques were learned during the first phase (month 1 to 3) of the 
lifestyle program. In phases 2, 3, and 4 (months 4 to 12), all techniques 
were repeated. Special themes like going on vacation or Christmas were 
also discussed. The exact outline of each session can be found in the 
study protocol (21). Each lifestyle group consisted of a maximum of 
10 patients to ensure that there was sufficient individual attention for 
every participant. We developed the “PCOS lifestyle textbook” for par-
ticipants, which described the activities of each group session and the 
homework assignments. To standardize the treatment and to facilitate 
the therapists’ treatment adherence, we developed a therapist manual 
that included protocols for each session. The Dutch Food Guide was 
used as a guideline for a healthy diet and daily amounts of food groups 
(24). Participants were advised to make small changes in their daily life 
according to this guideline. No caloric restriction was advised. More in-
formation about the daily amounts according to the Dutch Food Guide 
is provided in the study protocol (21). Physical therapists encouraged 
participants to plan exercise as part of their daily routine, according to 
the Global Recommendations on Physical Activity by the World Health 
Organization (25). Before the start of this study, we tested the inter-
vention in three pilot groups (n = 26). We examined the feasibility and 
acceptability of the LS program before enrolling participants. The data 
of these participants were not used in the current study.
LS program with SMS
Half of the participants in the LS group received additional support 
by tailored SMS via their mobile phone after 3 months of the LS 
Figure 1 CONSORT flowchart.
Assessed for eligibility 
(n=535) Excluded  (n=352)• Not meeting inclusion criteria (n=15)
• Pregnant before inclusion (n=36)
• Language barrier (n=16)
• Work and other commitments (n=69)
• Weight loss in own terms (n=98)
• Declined to participate (n=54)
• No show for inclusion  appointment (n=35)
• Didn’t want to lose weight (n=29)
Randomized (n=183)
60 Assigned to 
care as usual
16 pregnant during 
study
10 pregnant during 
study
14 pregnant during 
study
60 Assigned to 
SMS+
63 Assigned to 
SMS-
16 completed study24 completed study 27 completed study
28 Discontinued treatment:
No show for group meetings (n=10)
Dissatisfied with the intervention  (n=5)
Language barrier (n=3)
Work and other commitments (n=8)
Relationship ended (n=2)
26 Discontinued treatment:
No show for measurements (n=19)
No wish to conceive anymore (n=2)
Dissatisfied with the study (n=3)
Didn’t want to lose weight (n=1)
Partner not motivated  (n=1)
22 Discontinued treatment :
No show for group meetings (n=14)
Treatment abroad (n=2)
Dissatisfied with the intervention (n=3)
Work and other commitments (n=1)
Treatment for breast cancer (n=1)
Bariatric surgery (n=1)
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program. They received the same LS program as the participants 
without additional SMS support. Participants sent weekly self-moni-
tored information regarding their diet, physical activity, and emotions 
by SMS to the psychologist. Participants received feedback on their 
messages to provide social support, encourage positive behavior, and 
empower behavioral strategies. Also, participants received two mes-
sages per week addressing eating behavior (self-monitoring, barriers, 
binge eating, eating pace, emotional eating, food choices, portions, 
planning, preparation, stimulus control, social eating, sugar-sweet-
ened beverages) and physical activity (motivation, fun facts, seden-
tary behavior).
CAU
Participants in the CAU group received CAU, which included short, 
unstructured consultations with their treating physician at baseline and 
four consultations that were combined with the 3-, 6-, 9-, and 12-month 
study measurements. They were encouraged by their treating physician 
to lose weight through publicly available services (i.e., diets, visiting 
a dietitian, going to the gym, or participating in public programs such 
as Weight Watchers). The treating physician also mentioned the risk of 
overweight for both mother and child as well as the relation between 
overweight and fertility.
Statistical considerations
The original sample size calculation was based on a difference be-
tween the groups of 0.45 in terms of Cohen’s d in the primary out-
come variable (weight), with a power (1-β) of 0.80 and an α level of 
0.05 (two-sided). This resulted in 78 patients enrolled in the LS with 
SMS group, 78 patients in the LS without SMS group, and 78 patients 
in CAU, a total of 234. This number was registered at the Netherlands 
Trial Register. During an interim power analysis, we found an effect 
of Cohen’s d = 0.10 in CAU, whereas the LS group showed an effect 
of d = 0.52 (a difference of 0.42). Because of this large effect in the 
intervention group compared with CAU, we modified the original 
sample size calculation based on the method described by Aberson 
(26), with a power of 0.90, a two-sided α of 0.025 (corrected for 
the interim analysis as described in the study protocol), and five re-
peated measures linearly decreasing. We observed an intercorrelation 
of about 0.90 between all measurements. Maintaining a ratio of 1:1:1, 
the required sample was 42 in each group. With an expected dropout 
proportion of 30% (27), 60 participants in each group were needed 
for the study.
All variables were analyzed based on the intention-to-treat population, 
which is defined as all allocated participants. We performed additional 
analyses for the study completers, which means that we compared partic-
ipants with measurements at 12 months with participants who dropped 
out before 12 months. Multilevel regression modeling was applied for 
longitudinal analyses of the primary and secondary outcomes. Mixed 
modeling can efficiently deal with missing data and unbalanced time 
points (28). This also means that patients without complete follow-ups 
can be included in the analyses, without imputation. This method com-
pensates for selective dropout, on the condition that dropout is related 
to variables included in the models. This analysis included two levels: 
the patients constituted the upper level and their five repeated measures 
the lower level. The difference with ordinary linear regression is that 
this analysis takes into account the fact that measurements belong to a 
certain participant. Study group, linear and logarithmic time, and inter-
actions were included as independent variables. The deviance statistic 
(29) using restricted maximum likelihood (30) was applied to deter-
mine the covariance structure, so that it could take into account when, 
for example, the deviation at baseline was different from the deviations 
at follow-up. In case of a non-normal distribution, a bootstrap proce-
dure with 10,000 samples was performed to obtain a more reliable out-
come. The bootstrap mixed model analyses were performed with SPSS 
Statistics for Windows, version 25.0 (IBM Corp., Armonk, New York).
The proportions of participants who lost at least 5% or 10% weight 
were analyzed with multilevel logistic regression analyses. A binomial 
distribution was assumed. The multilevel logistic regression analyses 
using PROC GLIMMIX were performed in SAS version 9.4 (SAS 
Institute Inc., Cary, North Carolina).
Cohen’s d effect sizes were calculated by dividing the differences 
between time point and baseline estimations by the estimated baseline 
standard deviation (SD). Cohen’s d is used to describe the standardized 
mean difference of an effect. This value can be used to compare effects 
across studies, even when the dependent variables are measured in dif-
ferent units. For the interpretation of the effect sizes, the guidelines of 
Cohen were used: an effect size of 0.20 was considered a small effect, 
0.50 medium, and 0.80 a large effect (31). Values of P < 0.05 were con-
sidered significant.
Results
Between August 2, 2010, and March 11, 2016, 535 eligible women 
were asked to participate, and 209 provided written informed consent, 
of whom 26 were included in the pilot study. At baseline, 63 partici-
pants were randomized to the LS without SMS group and 60 to the LS 
with SMS group, and 60 received CAU. A total of 183 participants were 
available for the intention-to-treat analyses (Figure 1), and 487 mea-
surements in total were used for the analyses. The baseline characteris-
tics of participants are described in Table 1. Mean age was 29.1 ± 4.4 
years and the average infertility duration was 33.5 ± 31.7 months. 
Most participants (57.6%) had intermediate levels of education.
Weight loss
The mean weight loss was 2.32 kg in CAU, 4.65 kg in the LS without SMS 
group, and 7.87 kg in the LS with SMS group (within all groups, P < 0.001) 
at 12 months. Expressed in Cohen’s d, the effects for weight loss were very 
small in CAU (d = −0.16), small in the LS without SMS group (d = −0.32), 
and medium in the LS with SMS group (d = −0.55; Table 2).
The difference in weight loss between the LS and CAU groups was 
3.7 kg in favor of LS (d = −0.25; P < 0.001). If we compared the LS 
with SMS group with the LS without SMS group, we observed 3.2 kg 
more weight loss in LS with SMS (d = −0.22; P = 0.017). Expressed 
as BMI, LS participants achieved a reduction of 1.3 kg/m2 more 
than in CAU (d = −0.27; P < 0.001). In the LS with SMS group, a 
1.1-kg/m2 greater reduction was achieved than in LS without SMS 
(d = −0.24; P = 0.015).
Proportions of weight reduction
In CAU, 21.8% of the women had a weight reduction of more than 
5% compared with 52.8% of the women in the LS without SMS 
group and 85.7% in the LS with SMS group. The odds ratio of 
achieving a 5% weight loss was 7.0 (P < 0.001) in the LS compared 
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with CAU groups. The difference between the LS groups with or 
without SMS was not significant (P = 0.130). A 10% weight loss was 
achieved in 6.8% of the women in the CAU group and in 23.7% 
of the women in the LS groups. This difference was not significant 
(P = 0.100; Table 3).
Weight gain
Weight gain was observed in 29% of the women in the CAU group ver-
sus 8.5% in the LS without SMS group and 3.1% in the LS with SMS 
group. The odds ratio of gaining weight was 6.2 (P = 0.021) for the LS 
compared with CAU groups, in favor of LS (Table 3).
Waist, hip, and waist-hip ratio
Waist circumference decreased in all groups: 5.6 cm in the CAU 
group, 3.8 cm in the LS without SMS group, and 8.1 cm in the LS 
with SMS group. There was no significant decrease if we compared 
CAU with the LS groups (P = 0.950). We observed an insignificant 
trend between the LS without SMS and LS with SMS groups in 
favor of LS with SMS (P = 0.058,). Hip circumference decreased 
by 2.8 cm in the CAU group, 4.5 cm in the LS without SMS group, 
and 5.8 cm in the LS with SMS group (Table 2). Hip circumference 
decreased more in the LS groups compared with CAU (P = 0.027).
Dropout
In our study, we observed an overall dropout rate of 63.4%. There were 
no significant differences in dropout rates between the three arms of the 
study: 60.0% in the CAU group, 73.4% in the LS without SMS group, 
and 57.2% in the LS with SMS group (Figure 1). We performed addi-
tional analyses to test baseline differences between overall study com-
pleters and dropouts. Dropouts had a mean baseline weight of 91.2 kg 
(SD 13.8) compared with 95.6 kg in study completers (P = 0.004). Also, 
TABLE 1 Baseline characteristics by trial group
Care as usual, 
N = 60
Lifestyle intervention without 
SMS, N = 63
Lifestyle intervention with 
SMS, N = 60 Total, N = 183
Age (y) 28 [26-32] 30 [27-33] 28 [26-32] 29 [26-32]
Weight (kg) 84 [79-97] 89 [80-104] 95 [85-106] 90 [81-103]
BMI (kg/m2) 30.6 [29.3-34.3] 33.6 [30.4-36.0] 33.5 [30.9-37.1] 32.8 [30.1-36.1]
Waist (cm) 96 [89-109] 100 [93-107] 102 [94-110] 100 [92-107]
W/H ratio 0.8 [0.8-0.9] 0.9 [0.8-0.9] 0.8 [0.8-0.9] 0.9 [0.8-0.9]
Age of menarche (y) 12 [11-13] 12 [11-13] 12 [12-14] 12 [11-13]
Androgens
Testosterone (nmol/L) 1.53 [1.22-2.16] 1.64 [1.25-2.25] 1.50 [1.01-2.13] 1.53 [1.21-2.16]
SHBG (nmol/L) 29.1 [22.4-39.0] 29.8 [20.7-43.8] 26.0 [21.2-38.6] 27.6 [21.2-39.5]
FAI 5.4 [4.0-8.0] 5.1 [3.3-9.2] 6.3 [3.4-8.3] 5.8 [3.7-8.9]
Hirsutism score (mFG) 3 [1-6] 4 [2-9] 3 [1-9] 3 [1-8]
BMI classification
Overweight 22 (36.7) 12 (19.0) 9 (15.0) 4 (23.5)
Obesity class I 25 (41.7) 29 (46.0) 27 (45.0) 81 (44.3)
Obesity class II 7 (11.7) 14 (22.2) 14 (23.3) 35 (19.1)
Obesity class III 6 (10.0) 8 (12.7) 10 (16.7) 24 (13.1)
Education
Low 8 (14.3) 5 (8.2) 5 (8.3) 18 (10.2)
Intermediate 35 (62.5) 34 (55.7) 33 (55.0) 102 (57.6)
High 13 (23.2) 22 (36.1) 22 (36.7) 57 (32.2)
PCOS characteristics
OD 57 (95.0) 60 (96.8) 58 (96.7) 175 (96.2)
Regular 3 (5.0) 2 (3.2) 2 (3.3) 7 (3.8)
Oligomenorrhea 51 (85.0) 53 (85.5) 41 (68.3) 145 (78.7)
Amenorrhea 6 (10.0) 7 (11.3) 17 (28.3) 30 (16.5)
HA 47 (78.3) 49 (80.3) 48 (80.0) 144 (79.6)
Clinical 23 (38.3) 27 (45.0) 24 (40.0) 74 (41.1)
Biochemical 38 (63.3) 45 (72.6) 44 (73.3) 127 (69.8)
PCOM 59 (98.3) 58 (96.7) 58 (96.7) 175 (97.2)
AFC 58 (96.7) 58 (96.7) 58 (96.7) 174 (96.7)
Volume 26 (44.8) 25 (43.9) 29 (50.0) 80 (46.2)
Daa given as median [IQR] or n (%).
FAI, Free Androgen Index; HA, hyperandrogenism; mFG, modified Ferriman Gallwey; OD, ovulatory dysfunction; PCOM, polycystic ovarian morphology; SHBG, sex hormone–
binding globulin; W/H, waist-hip ratio; AFC, antral follicle cound.
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dropouts were significantly younger at baseline (P = 0.050), already 
had a child (P = 0.001), had a lower hip circumference (P = 0.039), were 
smokers (P < 0.001), and consumed alcohol (P = 0.001). Other baseline 
characteristics like time attempting to become pregnant and education 
levels were not significantly different between study completers and 
dropouts.
Discussion
Overall, we conclude that our group-based three-component lifestyle 
program that combined nutrition advice, exercise, and CBT resulted 
in relevant and sustainable weight loss in women with obesity and 
PCOS. The intervention with additional tailored SMS feedback 
resulted in more weight loss than the regular intervention. There is a 
growing recognition that women with PCOS need long-lasting treat-
ment for different PCOS characteristics, but especially patients who 
have overweight or obesity. Weight loss by LS has shown to be suc-
cessful in general (32). In PCOS groups, however, the effects have 
been moderate or tested in small sample sizes and/or results have 
been based on short-term interventions (3,11). Therefore, our RCT 
aimed to explore whether a three-component lifestyle program was 
effective for women with PCOS who need a long-term approach and 
whether it could result in a modest and sustainable weight loss.
To our knowledge, we performed the largest RCT investigating the 
effect of a three-component lifestyle program on weight loss in women 
with PCOS. Others have shown that lifestyle treatment in combination 
TABLE 2 Weight, BMI, waist, hip, and waist hip ratio estimates at baseline and 12 months
Group
Baseline 12 months Change, baseline - 12 months
Estimate Estimate Estimate Percent (%) Cohen’s d P value
Weight (kg)
Care as usual 89.5 87.2 −2.32 −2.6 −0.16 <0.001
Lifestyle without SMS 91.7 87.0 −4.65 −5.1 −0.32 <0.001
Lifestyle with SMS 96.5 88.7 −7.87 −8.1 −0.55 <0.001
BMI (kg/m2)
Care as usual 32.7 31.8 −0.85 −2.6 −0.18 <0.001
Lifestyle without SMS 33.9 32.3 −1.69 −5.0 −0.36 <0.001
Lifestyle with SMS 34.7 31.9 −2.80 −8.1 −0.60 <0.001
Waist (cm)
Care as usual 100.4 94.9 −5.56 −5.5 −0.44 <0.001
Lifestyle without SMS 100.1 96.3 −3.79 −3.8 −0.45 0.009
Lifestyle with SMS 102.9 94.8 −8.13 −7.9 −0.69 <0.001
Hip (cm)
Care as usual 115.6 112.9 −2.78 −2.4 −0.25 <0.001
Lifestyle without SMS 116.6 112.1 −4.49 −3.8 −0.41 <0.001
Lifestyle with SMS 120.4 114.6 −5.84 −4.8 −0.53 <0.001
Waist-hip ratio
Care as usual 0.9 0.8 −0.02 −2.2 −0.20 0.398
Lifestyle without SMS 0.9 0.9 0.00 −0.2 0.02 0.917
Lifestyle with SMS 0.9 0.8 −0.03 −3.6 −0.32 0.110
Cohen’s d: 0.20 = small effect, 0.50 = medium effect, and 0.80 = large effect.
TABLE 3 Proportions of weight changes between study groups
CAU LS without SMS LS with SMS LS vs. CAU
LS with SMS vs. LS 
without SMS
% [95% CI] % [95% CI] % [95% CI] OR [95% CI] P OR [95% CI] P
Weight loss 5% (kg) 21.8 [8.5-45.5] 52.8 [23.2-80.5] 85.7 [51.3-97.2] 7.0 [1.7-29.8] 0.008 5.4 [0.6-47.3] 0.129
Weight loss 10% (kg) 6.8 [1.7-23.5] 12.2 [3.2-36.7] 45.9 [15.4-79.8] 4.2 [0.8-23.5] 0.100 6.1 [0.7-50.0] 0.091
Weight gain (kg) 29.0 [13.3-52.0] 8.5 [2.2-27.3] 3.1 [0.3-24.8] 6.2 [1.3-28.6] 0.021 2.9 [0.2-42.9] 0.443
OR, odds ratio.
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with weight-loss medication, meal replacement products, and/or (very) 
low-calorie diets are successful only for a short period of time in women 
with PCOS (14,15,33,34). Many participants regain the lost weight 
because they find it difficult to adhere to medication, meal replacement 
products, and/or (very) low-calorie diets for long periods of time (35). 
This might explain why long-term results of such therapies are absent 
or disappointing. Recent studies have shown that a weight maintenance 
diet could be a long-term solution for women with PCOS (36,37). 
This is in line with the current study that is based on a full-fledged 
diet instead of meal replacement products and caloric restriction. We 
emphasized the importance of achieving an individual, healthy, and 
long-lasting eating pattern that is sustainable. Subjects were stimulated 
to make small healthier changes to their daily diet. A full-fledged diet 
is advised to develop a structured eating pattern to avoid overrestriction 
and underrestriction, like binge eating and restrained eating (38), and 
it can contribute to a long-term healthy lifestyle in women with PCOS.
A structured CBT program was used to standardize treatment in this 
group of women. In our CBT intervention, we used many different CBT 
techniques like self-monitoring of eating, setting specific achievable and 
quantifiable weekly goals, identifying internal eating cues and practice 
with alternative behaviors, cognitive restructuring of body weight reg-
ulation and unrealistic weight-loss expectations, and improving social 
support. Little is known about the possible mechanism through which 
LS achieve their effect or which components contribute the most to 
weight loss (39). For CBT itself, it is difficult to test predictors and 
mediators for success (40), especially for a group-based intervention 
with three components.
A limitation of the present trial is the high discontinuation rates we 
observed in all arms of the study. Compliance and dropout are the most 
difficult aspects of any weight-reduction intervention, especially in 
programs that last more than 42 weeks (9). About one-third of partic-
ipants drop out from general weight-loss programs (9), and this can 
even increase by up to 80% (41). Other studies reported dropout rates 
in one- and two-component programs for women with PCOS of around 
25% (9). The dropout rates tend to be highest within the first 3 months 
of a lifestyle program (42). Compared with our study, others found that 
baseline free testosterone, total testosterone, and less weight loss were 
characteristics associated with dropout during lifestyle treatment for 
women with PCOS (9). Although the rationale behind this association 
remains unclear, we expected to have relatively high discontinuation 
rates based on two reasons: firstly, the intervention was demanding 
for participants (the intervention took place on Monday afternoon and 
involved a 1-year commitment), and secondly, because pregnancy, 
which is the ultimate goal of the intervention, is considered a pushout 
for the intervention. In our sample calculations, we anticipated this.
A modest weight reduction of about 5% to 10% is linked to many health 
benefits in the general population (43), including women with PCOS 
(3). Some even suggested that a 5% weight loss has more benefits than 
a 10% or 15% weight loss, especially when this 5% weight loss is main-
tained (44). Also, a modest weight loss is a reasonable and achievable 
target for many individuals who are sensitive to weight regain (45) 
like women with PCOS (46). Our intervention succeeded in a modest 
weight loss of 5% to 10% maintained over 1 year according to the cur-
rent standards of successful weight loss (44). This is comparable with 
the 6.4-kg weight loss in the 16-week three-component intervention by 
Dokras and colleagues (19). It is worth questioning whether a 16-week 
intervention is comparable with a 1-year intervention, especially in 
regard to whether the results of a shorter program will be sustained in 
the future. Other CBT-based LS for women with PCOS have resulted 
in a weight loss of 4.3% (16), 2.1% (18), and around 1% (17), respec-
tively, and have not been able to succeed in a 5% to 10% weight loss.
However, our study also showed that even with the aid of an intensive, 
long-term, three-component intervention, it is hard to achieve more than 
a moderate weight loss. Substantial weight loss (>10%) was achieved in 
a small number of women. The additional tailored SMS feedback seemed 
to result in more weight loss than the intervention without SMS. Two 
meta-analyses have shown that adding SMS is effective in reinforcing 
behavioral skills that were learned during LS (47). Personalized SMS 
interventions were particularly effective through greater patient engage-
ment (48). Our intervention with SMS was designed to target multiple 
lifestyle behaviors and it consisted of text messages based on self-mon-
itored information of the participants. Many participants were positive 
about the personal attention they received through the SMS and they found 
the reminders helpful when no group meetings were scheduled. Although 
SMS might be a little outdated, the mechanism of the intervention with 
SMS is comparable with other more modern E-health techniques.
Despite the positive results, the actual potential for weight loss is much 
higher than the achieved effects of this intervention. Therefore, new 
studies might be able to explore those potentials and discover more 
effective and more cost-effective treatment options. These develop-
ments would help many women with PCOS who struggle with their 
weight. Our hospital will implement the three-component intervention 
as standard care, which will allow subgroup analyses to find out what is 
most effective for whom. Furthermore, we hope to test the relationship 
between spontaneous pregnancies and the amount of weight loss, mis-
carriages, and live birth rates, along with cost-effectiveness.
Conclusion
Overall, we conclude that a group-based three-component lifestyle 
program that combines nutrition advice, exercise, and CBT resulted in 
reasonable weight loss in women with obesity and PCOS. Additional 
tailored SMS feedback seems useful to remind, encourage, and moti-
vate participants in the intervention and to increase the odds of achiev-
ing weight loss.O
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